Resource Center

This section contains international research and may reference indications not approved in all regions. Please consult local approved indications before use.

Filter By:

Search
resources-top-bg
Home ultrasound and CTG are potentially feasible and acceptable to high-risk pregnant women. Larger studies are required to refine how best to implement such devices within clinical practice. To our
The home ultrasound device was feasible, comparable, and well-correlated with standard IC scans, laying the basis for remote home-based monitoring of follicular development during ovarian stimulation. We believe this also
In this large-scale, retrospective real-world study, we aimed to examine the association between home ultrasound service utilization during pregnancy and adverse pregnancy outcomes.
Remote visits had a success rate of 97.4% (38 of 39), with significantly shorter durations compared with in-clinic visits (median 59.0 min vs. 159.0 min, P
With appropriate patient selection, some older, chronically ill patients can generate high-quality LUS self-images that are non-inferior to those generated by trained physicians using the same device, thereby enabling remote
Pulsenmore ES is a self-scanning ultrasound system for remote fetal assessment. It is composed of a hand-held transducer that serves as a smartphone cradle coupled with an application and clinician’s
resources-bottom-bg

the news pulse

We invite you to keep up to date with the latest updates by registering to our quarterly newsletter

news-pulse-doctor
news-pulse-lady1
news-pulse-couple
news-pulse-lady2
about-collaborations-bottom-bg

FAQ

Frequently asked question

The Pulsenmore was designed to follow ALARA (As Low As Reasonably Achievable) principles as follows:

The system supports only low frequency (2-5MHz), the duration of the scan is limited up to 3 minutes in the App guided mode, or at the clinician’s discretion in the clinician guided mode, only clinician can modify the ultrasound parameters (i.e., depth, gain, frequency etc.), each scan is enabled only upon the approval of a medical professional. The system was authorized by FDA through the de novo classification process.